COVID VMS Boom Driving Shift To Self-Care As The Netherlands Bucks 2020 Sales Trends
Executive Summary
Despite the pandemic, the Dutch OTC market recorded impressive growth of 4.6% in 2020. HBW Insight speaks to Bernard Mauritz, director of the Netherlands' self-care industry association, Neprofarm, about how the country bucked negative sales trends seen in other European OTC markets.
You may also be interested in...
Dutch Pandemic-Related Sales Boost Peaks In 2021, Pharmacy Rout Continues
The Netherlands' OTC market stabilizes in 2021, after defying the negative impacts of COVID-19 seen in other major European markets the year before. Consumers continued to flock to drugstores and supermarkets rather than pharmacies, highlighting the ongoing structural transformation of the country's consumer health market.
Italy’s OTC Market Records Worst Performance In 15 Years
Italy's non-prescription drug market was hit hard by the effects of COVID-19 in 2020, with volume sales down almost 9% on the previous year.
Dutch OTC Market in 2019: VMS Delisting Accelerates Shift Towards Self-Care
A delisting of vitamin D and calcium food supplements accelerates a long-term shift towards self-care among Dutch consumers, according to the latest market data from local industry association, Neprofarm, in collaboration with IQVIA.